These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 19885608)

  • 61. Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma.
    Chen K; Sawhney R; Khan M; Benninger MS; Hou Z; Sethi S; Stephen JK; Worsham MJ
    Arch Otolaryngol Head Neck Surg; 2007 Nov; 133(11):1131-8. PubMed ID: 18025318
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.
    Honorio S; Agathanggelou A; Wernert N; Rothe M; Maher ER; Latif F
    Oncogene; 2003 Jan; 22(3):461-6. PubMed ID: 12545168
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing.
    Tokumaru Y; Yamashita K; Osada M; Nomoto S; Sun DI; Xiao Y; Hoque MO; Westra WH; Califano JA; Sidransky D
    Cancer Res; 2004 Sep; 64(17):5982-7. PubMed ID: 15342377
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Aberrant Epigenetic Regulation in Head and Neck Cancer Due to Distinct EZH2 Overexpression and DNA Hypermethylation.
    Mochizuki D; Misawa Y; Kawasaki H; Imai A; Endo S; Mima M; Yamada S; Nakagawa T; Kanazawa T; Misawa K
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30469511
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients.
    Pierini S; Jordanov SH; Mitkova AV; Chalakov IJ; Melnicharov MB; Kunev KV; Mitev VI; Kaneva RP; Goranova TE
    Head Neck; 2014 Aug; 36(8):1103-8. PubMed ID: 23804521
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer.
    Guerrero-Preston R; Michailidi C; Marchionni L; Pickering CR; Frederick MJ; Myers JN; Yegnasubramanian S; Hadar T; Noordhuis MG; Zizkova V; Fertig E; Agrawal N; Westra W; Koch W; Califano J; Velculescu VE; Sidransky D
    Epigenetics; 2014 Jul; 9(7):1031-46. PubMed ID: 24786473
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma.
    Weiss D; Stockmann C; Schrödter K; Rudack C
    Cell Oncol (Dordr); 2013 Jun; 36(3):213-24. PubMed ID: 23529585
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
    Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
    [TBL] [Abstract][Full Text] [Related]  

  • 70. DNA methylation regulated microRNAs in HPV-16-induced head and neck squamous cell carcinoma (HNSCC).
    Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M
    Mol Cell Biochem; 2018 Nov; 448(1-2):321-333. PubMed ID: 29455435
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Promoter hypermethylation of tumor-associated genes in head and neck cancer].
    Okami K; Sakai A; Onuki J; Hamano T; Iida M; Takahashi M
    Nihon Jibiinkoka Gakkai Kaiho; 2005 Mar; 108(3):207-13. PubMed ID: 15828286
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Integrative computational analysis of transcriptional and epigenetic alterations implicates DTX1 as a putative tumor suppressor gene in HNSCC.
    Gaykalova DA; Zizkova V; Guo T; Tiscareno I; Wei Y; Vatapalli R; Hennessey PT; Ahn J; Danilova L; Khan Z; Bishop JA; Gutkind JS; Koch WM; Westra WH; Fertig EJ; Ochs MF; Califano JA
    Oncotarget; 2017 Feb; 8(9):15349-15363. PubMed ID: 28146432
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Novel approaches to global mining of aberrantly methylated promoter sites in squamous head and neck cancer.
    Worsham MJ; Chen KM; Stephen JK; Havard S; Benninger MS
    Otolaryngol Head Neck Surg; 2010 Jul; 143(1):116-21, 121.e1-19. PubMed ID: 20620629
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa.
    Paluszczak J; Misiak P; Wierzbicka M; Woźniak A; Baer-Dubowska W
    Oral Oncol; 2011 Feb; 47(2):104-7. PubMed ID: 21147548
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Microbiomic subprofiles and MDR1 promoter methylation in head and neck squamous cell carcinoma.
    Bebek G; Bennett KL; Funchain P; Campbell R; Seth R; Scharpf J; Burkey B; Eng C
    Hum Mol Genet; 2012 Apr; 21(7):1557-65. PubMed ID: 22180460
    [TBL] [Abstract][Full Text] [Related]  

  • 76. KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses.
    Demokan S; Chang X; Chuang A; Mydlarz WK; Kaur J; Huang P; Khan Z; Khan T; Ostrow KL; Brait M; Hoque MO; Liegeois NJ; Sidransky D; Koch W; Califano JA
    Int J Cancer; 2010 Nov; 127(10):2351-9. PubMed ID: 20162572
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of epigenetic inactivation of vascular endothelial growth factor receptors in head and neck squamous cell carcinoma.
    Misawa Y; Misawa K; Kawasaki H; Imai A; Mochizuki D; Ishikawa R; Endo S; Mima M; Kanazawa T; Iwashita T; Mineta H
    Tumour Biol; 2017 Jul; 39(7):1010428317711657. PubMed ID: 28718364
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characterization of gene methylation in human papillomavirus associated-head and neck squamous cell carcinoma.
    Zhang HZ; Shan CG; Huang AP; Wang JM
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706614
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis.
    Misawa K; Mochizuki D; Endo S; Mima M; Misawa Y; Imai A; Shinmura K; Kanazawa T; Carey TE; Mineta H
    Mol Carcinog; 2017 Mar; 56(3):1107-1116. PubMed ID: 27685843
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Association of FANCC and PTCH1 with the development of early dysplastic lesions of the head and neck.
    Ghosh A; Ghosh S; Maiti GP; Mukherjee S; Mukherjee N; Chakraborty J; Roy A; Roychoudhury S; Panda CK
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S528-38. PubMed ID: 21861228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.